Abbott Laboratories
This coming earnings season could decide if a stock market at record highs has more room to run
The upcoming earnings season will show investors whether the bull case for equities still holds. The second quarter reporting season comes at a pivotal point for the stock market, with the S & P 500 and Nasdaq Composite trading at all-time highs this week even after an onslaught of bad news regarding higher tariffs, a […]
Read More
These 6 portfolio names pledged big U.S. investments since Trump took office again
Many of the biggest U.S. companies have pledged to invest trillions of dollars in the United States since President Donald Trump started his second term — including six names in our portfolio. These moves are aimed at aligning companies with the president’s vision for a new global trade order designed to bring manufacturing jobs back […]
Read More
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Jgi/jamie Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Tariff threats — and efforts to get into President Donald Trump’s good graces — are fueling a new wave […]
Read More
Corporate America shelled out millions for Trump’s inauguration. Now he’s upending many of their businesses
U.S. President Donald Trump delivers remarks at the Business Roundtable’s quarterly meeting at the Business Roundtable headquarters on March 11, 2025 in Washington, DC. Andrew Harnik | Getty Images America’s richest and most powerful companies shelled out millions to fund President Donald Trump’s inauguration festivities. Three months later, some may be asking whether the famously […]
Read More
Danaher’s quarterly results show signs of life, and the struggling stock soars
Danaher shares on Tuesday climbed more than 6% after the health-care company’s first-quarter results exceeded expectations — and, crucially, its guidance was left mostly intact despite an evolving economic picture. Count us among the investors breathing a sigh of relief. Revenue for the three months ended March 31 declined 1% year over year to $5.74 […]
Read More
These are the 4 biggest things we’re watching in the stock market in the week ahead
The stock market heads into Monday on a streak of volatility it just can’t seem to shake. What had been shaping up as a positive holiday-shortened week turned on a dime Wednesday when Federal Reserve Chairman Jerome Powell signaled concern that President Donald Trump ‘s tariffs could increase inflation and slow economic growth. Speaking at […]
Read More
Abbott Labs shares surge on earnings and a big sign of confidence in the business
Shares of Abbott Laboratories jumped Wednesday after the diversified health-care company delivered strong first-quarter results and left its earnings guidance intact — a big sign of confidence in an uncertain time. Revenue in the three months ended March 31 rose 4% to $10.36 billion, narrowly missing the consensus of $10.4 billion, according to estimates compiled […]
Read More
S&P 500 futures slide as Nvidia shares tumble, traders await retail sales data: Live updates
A trader works on the floor at the New York Stock Exchange on April 15, 2025. Brendan McDermid | Reuters U.S. stock futures slipped early Wednesday as investors looked ahead to the release of a key retail sales report and more earnings from the first-quarter season. Dow Jones Industrial Average futures dropped 328 points, or […]
Read More
Earnings season ramps up next week with no certainty for Wall Street on trade
The roller-coaster ride the stock market has been on is unlikely to end next week, with earnings ramping up in an environment where investors, companies and consumers have absolutely no certainty as to what will happen next with trade. Wall Street is about to wrap up one of its wildest weeks of trading ever, that […]
Read More
We’re booking profits in a rallying rotation play and using the cash to buy 2 others on the dip
We are making a handful of more trades Tuesday. Selling 75 shares of GE Healthcare at roughly $86 each; following the trade, Jim Cramer’s Charitable Trust will own 550 shares of GEHC, decreasing its weighting to about 1.43% from about 1.62% We are buying 50 shares of TJX at roughly $116; following the trade, the […]
Read More